ADO Antibody
- 
								中文名稱:ADO兔多克隆抗體
- 
								貨號(hào):CSB-PA937425
- 
								規(guī)格:¥1100
- 
								圖片:
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:ADO
- 
											別名:2 aminoethanethiol dioxygenase antibody; 2-aminoethanethiol dioxygenase antibody; ADO 2 aminoethanethiol (cysteamine) dioxygenase antibody; ADO antibody; AEDO_HUMAN antibody; C10orf22 antibody; Chromosome 10 open reasing frame 22 antibody; cysteamine (2-aminoethanethiol) dioxygenase (ADO) antibody; Cysteamine dioxygenase antibody; DKFZp564C046 antibody; FLJ14547 antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human,Mouse
- 
											免疫原:Synthetic peptide of Human ADO
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:Non-conjugated
- 
											抗體亞型:IgG
- 
											純化方式:Antigen affinity purification
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:ELISA,WB
- 
											推薦稀釋比:Application Recommended Dilution ELISA 1:1000-1:2000 WB 1:200-1:1000 
- 
											Protocols:
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
Most popular with customers
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
  
 













 
         
           
  
          